61 Biggest Movers From Yesterday
Gainers
Newegg Commerce, Inc. (NASDAQ: NEGG) shares surged 148.4% to close at $67.57 on Wednesday after jumping around 42% on Tuesday.
Mid-Afternoon Market Update: Dow Rises 70 Points; IDEAYA Biosciences Shares Slide
Toward the end of trading Wednesday, the Dow traded up 0.20% to 34,647.52 while the NASDAQ rose 0.01% to 14,664.04. The S&P also rose, gaining 0.33% to 4,358.01.
Why Shares Of OncoSec Medical Are Trading Higher Today
OncoSec Medical (NASDAQ: ONCS) shares are trading higher after the company announced it entered into a Clinical Trial Collaboration and Supply Agreement with Merck to evaluate the combination of OncoSec's TAVO with Merck's KEYTRUDA in a Phase 3 study.
Mid-Day Market Update: Crude Oil Down 2.5%; Opiant Pharmaceuticals Shares Jump
Midway through trading Wednesday, the Dow traded down 0.23% to 34,499.42 while the NASDAQ fell 0.30% to 14,619.40. The S&P also fell, dropping 0.11% to 4,338.70.
42 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Newegg Commerce, Inc. (NASDAQ: NEGG) jumped 79% to $48.70 after jumping around 42% on Tuesday.
Mid-Morning Market Update: Markets Mostly Flat; MSC Industrial Direct Tops Q3 Views
Following the market opening Wednesday, the Dow traded up 0.01% to 34,581.04 while the NASDAQ rose 0.06% to 14,671.71. The S&P also rose, gaining 0.08% to 4,347.22.
OncoSec Stock Jumps On Anti-Cancer Gene Therapy Trial Collaboration With Merck In Melanoma
OncoSec Medical Inc (NASDAQ:ONCS) will evaluate its DNA-plasmid interleukin-12 (IL-12) TAVO (tavokinogene telseplasmid) with Merck & Co Inc’s (NYSE:MRK) Keytruda (pembrolizumab)…
The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 6)